Gene: CCDC30
Official Full Name: coiled-coil domain containing 30provided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19026 | CCDC30 Knockout cell line (HeLa) | Human | CCDC30 | 1:3~1:6 | Negative | Online Inquiry |
KO19027 | CCDC30 Knockout cell line (HCT 116) | Human | CCDC30 | 1:2~1:4 | Negative | Online Inquiry |
KO19028 | CCDC30 Knockout cell line (HEK293) | Human | CCDC30 | 1:3~1:6 | Negative | Online Inquiry |
KO19029 | CCDC30 Knockout cell line (A549) | Human | CCDC30 | 1:3~1:4 | Negative | Online Inquiry |
CCDC30 Gene Knockout Cell Lines are a cutting-edge biological research tool designed to investigate the functions of the CCDC30 gene, pivotal in various cellular processes. These cell lines have been genetically engineered to disable the expression of CCDC30, enabling researchers to analyze the resulting phenotypic and molecular changes within the context of specific biological pathways.
The primary function of CCDC30 Gene Knockout Cell Lines lies in their ability to elucidate the role of CCDC30 in processes such as cell division, differentiation, and intracellular signaling. By employing CRISPR-Cas9 technology for precise gene editing, these knockout cell lines provide a unique chance to study the resultant variations in gene expression profiles, protein interactions, and cellular responses. This mechanistic insight can pave the way for a deeper understanding of diseases where CCDC30 is involved, including potential implications in cancer biology and developmental disorders.
From a scientific perspective, CCDC30 Gene Knockout Cell Lines hold significant value in both research and clinical settings. They serve as an essential tool for drug discovery, allowing for high-throughput screening of therapeutic compounds targeting CCDC30-related pathways. Additionally, they contribute to biomarkers identification, which can facilitate the development of targeted therapies for diseases originating from dysregulation of the CCDC30 gene.
Unlike traditional cell models, these knockout lines provide a more reliable and reproducible system for researchers, thus yielding highly specific details regarding gene function and associable pathways. This specificity reduces the risk of off-target effects seen in other genetic manipulation methods and allows for a clearer understanding of gene-environment interactions.
The intrinsic advantages of CCDC30 Gene Knockout Cell Lines make them invaluable assets for researchers, clinicians, and biotech companies aiming to decode the complexities of genetic functions and their implications in health and disease. Given our company’s robust foundation in genetic engineering and cell line development, we ensure that our products represent the highest standard in accuracy, reliability, and applicability, empowering scientists to push the boundaries of biological research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.